Lost Money on Applied Therapeutics, Inc. (APLT)? Contact Levi & Korsinsky Regarding an ...
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied ...
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
STAR-1 topline results expected in March 2025 - - Over 30 million acne patients seek treatment in the U.S. each year - - Phase 2b for DMT310 achieved statistically significant r ...
Verve Therapeutics: Cutting-Edge Science But Highly Risky Stock
Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...
TMCnet10 小时
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
Independent valuation of PsyLabs values Psyence Biomed’s stake at approximately $2 million, doubling in value. Debt-for-equity swap with Psyence Group and Newcourt SPAC Sponsor ...
Applied Therapeutics因药物研究面临FDA审查
据该公司称,FDA的检查产生了某些观察结果,Applied Therapeutics已经做出回应,并认为已解决任何未决问题。公司表示,所提到的给药错误导致少数患者的药物水平略低于目标水平,但在维持剂量阶段之前已得到纠正。Applied Therapeutics坚持认为,所有必要的详细记录都按照FDA规定保存,并已提供给该机构。
Optimistic Outlook for Applied Therapeutics Despite FDA Setback
Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on APLT stock, giving a Buy rating on November 29.Don't Miss our ...
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...